NURS FPX 4015 Assessment 5 Comprehensive Head-to-Toe Assessment

Grace J.
March 18, 2026March 18, 2026
BSN, Capella University, NURSFPX4015

Student Name

Capella University

NURS-FPX4015 Pathophysiology, Pharmacology, and Physical Assessment: A Holistic Approach to Patient-Centered Care

Prof. Name

Date

Comprehensive Head-to-Toe Assessment

This comprehensive evaluation offers a detailed overview of the patient’s overall health by combining subjective complaints, objective clinical observations, and general well-being indicators. In addition to the routine physical examination, specific attention is given to blood glucose levels, cardiovascular functioning, and foot integrity. These aspects are especially important in individuals with diabetes, as they help identify early complications related to impaired circulation and nerve damage. Early recognition of such risks allows timely interventions that support health promotion and prevent further deterioration. The outcomes of this assessment are used to develop an individualized care plan aligned with the patient’s specific health needs and long-term goals.

Introduction to Assessment

The assessment begins with a structured introduction to establish rapport and explain the process. The patient is informed that a head-to-toe evaluation will be conducted, including both physical observations and symptom-related questions. This approach ensures a holistic understanding of the patient’s condition.

The patient presents as alert, oriented, and able to communicate effectively. Sleep patterns appear adequate, with approximately eight hours of rest reported each night. Home-monitored vital signs indicate an average blood pressure of 140/85 mmHg and a heart rate ranging from 78 to 82 beats per minute. Blood glucose levels have been recorded between 130–140 mg/dL, and the most recent hemoglobin A1C is 8.9%, suggesting suboptimal glycemic control.

The patient has a medical history significant for hypertension, hyperlipidemia, and newly diagnosed type 2 diabetes mellitus. Current medications include metoprolol (50 mg twice daily), atorvastatin (80 mg daily), and gabapentin for neuropathic symptoms. Additionally, the patient reports the use of Tung seed as an herbal supplement.

Family history reveals a strong predisposition to metabolic and cardiovascular conditions, including diabetes, hypertension, and hyperlipidemia. Lifestyle patterns include moderate physical activity, such as walking on weekends, and dietary habits that include processed and fast foods, which may contribute to disease progression.

Physical Examination Findings

Eyes and Oral Cavity

Question: What findings were observed in the eyes and oral cavity, and what is their significance?

The patient’s eyes appear clear, with no redness or yellow discoloration, indicating no immediate signs of infection or jaundice. Vision is reported as normal; however, continued monitoring is essential due to the risk of diabetic retinopathy. Examination of the oral cavity reveals mild dryness of the lips and tongue, which may be associated with dehydration or increased thirst commonly linked to elevated blood glucose levels.

Neurological and Sensory Assessment

Question: What neurological symptoms are present, and what do they indicate?

The patient reports sensations of tingling and burning in both feet, with a pain intensity rated at 5 out of 10. Sensory testing indicates reduced ability to distinguish between sharp and dull stimuli. Despite these findings, motor function remains intact, with no reported weakness or abnormal movements. Occasional lightheadedness is noted. These symptoms are consistent with peripheral neuropathy, a common complication of diabetes resulting from prolonged hyperglycemia.

Skin, Circulation, and Extremities

Question: What does the assessment of the skin and circulation reveal?

The skin of the lower extremities shows normal coloration without cyanosis, though mild dryness is present. No ulcers or open lesions are identified. Peripheral pulses, including dorsalis pedis and posterior tibial, are palpable but reduced in strength. The skin is warm overall; however, slightly cooler toes suggest early signs of compromised blood flow. No swelling is observed. These findings may indicate early peripheral arterial involvement.

Cardiovascular Assessment

Question: What are the key cardiovascular findings?

The patient demonstrates a regular heart rhythm without complaints of chest pain, palpitations, or shortness of breath. Blood pressure remains elevated at 140/85 mmHg. A stenotic murmur is auscultated at the fourth intercostal space, consistent with previous findings and suggestive of possible arterial narrowing. These observations highlight an increased risk for cardiovascular complications.

Summary of Key Findings

System	Observation	Clinical Significance
Eyes	Clear, no redness or jaundice	Indicates stable vision but requires monitoring due to diabetes
Oral Cavity	Dry lips and tongue	Suggests dehydration or hyperglycemia
Neurological	Tingling, burning, reduced sensation	Indicative of peripheral neuropathy
Cardiovascular	Elevated BP, regular HR, murmur present	Increased cardiovascular risk
Skin	Mild dryness, no wounds	Early warning signs without active lesions
Circulation	Reduced peripheral pulses	Suggests risk of peripheral arterial disease

Discussion of Diagnosis and Findings

Question: What diagnosis is supported by the assessment findings?

The patient’s symptoms and clinical findings are consistent with type 2 diabetes mellitus complicated by peripheral neuropathy (Bodman & Varacallo, 2024). The elevated hemoglobin A1C level of 8.9% indicates chronic hyperglycemia, which contributes to both nerve damage and microvascular complications.

Additionally, the coexistence of hypertension and hyperlipidemia further increases the risk of vascular impairment. Family history also plays a significant role in increasing susceptibility to both metabolic and cardiovascular diseases. These combined factors emphasize the need for comprehensive management targeting glucose control, vascular health, and symptom relief (Bays, 2021).

Understanding of Pharmacological Needs

Question: What are the primary goals of pharmacological management?

The treatment strategy focuses on three main objectives: controlling blood glucose levels, reducing neuropathic symptoms, and minimizing cardiovascular risks. Antidiabetic medications help regulate glucose levels and prevent further complications. Gabapentin is used to manage nerve-related pain, while atorvastatin and metoprolol support cardiovascular health by lowering cholesterol and controlling blood pressure.

Potential side effects must be carefully monitored, including gastrointestinal disturbances, dizziness, and muscle pain (Cleveland Clinic, 2025; Mayo Clinic, 2024).

Medication	Purpose	Potential Side Effects
Metformin	Regulates blood glucose	Nausea, gastrointestinal upset
Gabapentin	Reduces nerve pain	Drowsiness, dizziness
Atorvastatin	Lowers cholesterol	Muscle discomfort
Metoprolol	Controls blood pressure	Fatigue, dizziness
Tung Seed	Herbal supplement	Possible drug interactions

Education Plan

Question: What education should be provided to the patient?

Patient education should focus on medication adherence, lifestyle modifications, and preventive care. The patient should be encouraged to take medications as prescribed and report any adverse effects promptly. Daily monitoring of blood glucose, maintaining a balanced diet, and engaging in regular physical activity are essential for improving overall health outcomes (Yang et al., 2025).

Foot care is particularly critical in preventing complications. Patients should inspect their feet daily, wear properly fitting footwear, and avoid injuries that may lead to infections (American Diabetes Association, 2024).

Understanding the Pathophysiology

Question: How does type 2 diabetes lead to complications such as neuropathy?

Type 2 diabetes is characterized by insulin resistance, which prevents efficient glucose uptake by cells, leading to elevated blood sugar levels (CDC, 2024). Over time, persistent hyperglycemia damages small blood vessels and peripheral nerves, particularly in the lower extremities. This results in symptoms such as tingling, burning, and pain.

Chronic complications may also affect other organs, including the eyes and kidneys, due to widespread vascular damage (Yachmaneni et al., 2023).

Critical Thinking and Clinical Reasoning: Establishing Care Priorities

Question: What are the priority areas in patient care?

The primary care priorities include achieving stable blood glucose levels, preserving nerve function, improving circulation, and reducing cardiovascular risk. Preventive strategies such as early detection of complications and consistent monitoring are essential.

These priorities align with established guidelines that emphasize glycemic control, routine foot assessments, and cardiovascular risk reduction (ADA, 2023).

Conclusion

Effective management of this patient’s condition requires a combination of pharmacological treatment, lifestyle modifications, and ongoing monitoring. By adhering to prescribed therapies and preventive strategies, the patient can reduce symptoms, prevent complications, and improve overall quality of life. Continuous education and support play a vital role in ensuring long-term success and patient confidence in self-care practices.

References

American Diabetes Association (ADA). (2023). American diabetes association releases 2023 standards of care in diabetes to guide prevention, diagnosis, and treatment for people living with diabetes. https://diabetes.org/newsroom/american-diabetes-association-2023-standards-care-diabetes-guide-for-prevention-diagnosis-treatment-people-living-with-diabetes

American Diabetes Association. (2024). Standards of care in diabetes.

Bays, H. (2021). Ten things to know about ten cardiovascular disease risk factors. American Journal of Preventive Cardiology, 5(100149), 100149. https://doi.org/10.1016/j.ajpc.2021.100149

Bodman, M. A., & Varacallo, M. (2024). Diabetic neuropathy. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK442009/

Centers for Disease Control and Prevention (CDC). (2024). About insulin resistance and type 2 diabetes. https://www.cdc.gov/diabetes/about/insulin-resistance-type-2-diabetes.html

Cleveland Clinic. (2025). Side effects of metformin: Watch out for these signs. https://health.clevelandclinic.org/side-effects-of-metformin